<!DOCTYPE html>

<!--
  Created : 1/26/2012 2:01 PM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../DocsLightBlue.png'>
<a href='EPOPump.html'><img src='../../Back.PNG'></a>
<p>EPOPump.Rate
<p>Overview
<p>The EPO Pump enables the model user to change <br>[EPO] levels by infusing EPO at different rates. <br>The switch enables the model user to turn the <br>pump on; the setting enables a particular rate of<br>infusion.<br><br>The anemia of chronic renal disease is often a <br>result of a lack of erythropoietin. Administration <br>of EPO using the pump illustrates the beneficial <br>effects of EPO in those patients.<br><br>Data is taken from a variety of human and animal <br>studies relating infusion rates to plasma <br>concentrations of EPO.<br><br>Human Data:<br>Eschbach JW,Kelly MR, Haley NR, Abels RI, Adamson JW<br>Treatment of the anemia of progressive renal failure <br>with recombinant human erythropoetin.<br>New Engl J Medicine 321:158-163, 1989<br><br>Winearls CG, Oliver DO, Pippard MJ, Reid C,<br>Downing MR, Cotes PM. Effect of human erythropoietin<br>derived from recombinant DNA on the anaemia of patients <br>maintained by chronic haemodialysis.<br>Lancet 2:1175-1178, 1986<br><br>Rat Data<br>Reissmann KR, Diederich DA, Ito K, Schmans JW.<br>Influence of disappearance rate and distribution <br>space on plasma concentration of erthropoietin <br>in normal rats. J Lab Clin Med 65:967-975, 1965
<p>Physical Units
<p>[Plasma] mU/mL<br>Flux  U/min
<p>Concentration Units
<p>Typical [EPO] is 20mU/mL at a secretion rate of 0.67U/min<br>Tau = 3days. K =1/Tau
<p>See Also
<p>EPOPump.Setting

<p><img src='../../Footer.PNG'>

</body>
</html>
